CANADA LIFE ASSURANCE Co
InsurancePosition in GILD — Gilead Sciences, Inc.
CIK 1046192
WINNIPEG, A2
Position in GILD
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$233,581,750
+$26,784,366 QoQ
Shares Held
1,675,983
-0.5% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.43%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026CANADA LIFE ASSURANCE Co holds $2,873,352,929 across 9 Drug Manufacturers - General names. GILD ranks #6 (8.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,567,817 | $627,677,187 | |
| 2 | LLY |
ELI LILLY & Co
|
630,459 | $579,877,274 | |
| 3 | ABBV |
AbbVie Inc.
|
1,742,412 | $378,957,185 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,974,102 | $357,754,728 | |
| 5 | AZN |
Astrazeneca PLC
|
1,521,866 | $300,142,412 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
1,675,983 | $233,581,750 | |
| 7 | PFE |
Pfizer Inc
|
6,657,890 | $186,953,551 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,068,316 | $186,093,365 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $233,581,750 | 1,675,983 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $206,797,384 | 1,684,841 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $250,396,908 | 2,255,828 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $246,969,355 | 2,227,558 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $246,035,468 | 2,195,765 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $193,668,853 | 2,096,664 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $181,849,546 | 2,169,007 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $146,279,333 | 2,132,041 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $132,511,887 | 1,809,036 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $144,830,650 | 1,787,812 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $136,184,565 | 1,817,248 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $139,539,396 | 1,810,554 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $134,317,477 | 1,618,868 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $135,048,402 | 1,573,074 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $121,823,129 | 1,974,763 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $124,133,455 | 2,008,307 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $120,596,584 | 2,028,538 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $139,225,899 | 1,917,448 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $119,639,080 | 1,712,800 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $116,291,869 | 1,688,816 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $118,869,564 | 1,839,232 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $127,131,474 | 2,182,140 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $131,256,307 | 2,077,169 | Shares | Defined | 2020-11-18 | |
| 2020-06-30 | $160,076,131 | 2,080,532 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $163,745,779 | 2,190,286 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||